Evogene Market Cap

Evogene has a market cap or net worth of 37.25 million as of August 14, 2025. Its market cap has decreased by -65.50% in one year.

Market Cap

37.25M

Enterprise Value

69.96M

Revenue

25.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

440.70

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 37.25M, a decrease of -67.08%. That is a compound annual growth rate of -6.04%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	37.25M	-21.33%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	64.35B
Danel (Adir Yeoshua)	2.50B
Kamada	1.43B
Bait Bakfar	1.06B
SofWave Medical	977.04M
BrainsWay	772.64M
Novolog (Pharm-Up 1966)	709.61M
Ilex Medical	673.41M

Market Cap Rankings